A Study Prevalence of Congenital Rubella Syndrome Cases Before and After Rubella Vaccination Campaign

Indian J Otolaryngol Head Neck Surg. 2023 Dec;75(4):2913-2920. doi: 10.1007/s12070-023-03882-3. Epub 2023 May 25.

Abstract

Rubella is a vaccine-preventable disease and is the leading cause of congenital disabilities. This study was performed to identify the congenital rubella syndrome (CRS) patients before and after the Rubella Vaccination Campaign in the Outpatient Unit of the Audiology Department at Dr. Soetomo General Hospital Surabaya. This was a descriptive study that used secondary data from a CRS surveillance case investigation form and medical records from 2015 to 2020 at Dr. Soetomo Hospital. A total of 346 suspected CRS cases were included in this study. According to the final classification, 145 (41.9%) patients had clinical CRS, 65 (18.8%) had confirmed CRS, and 136 (39.3%) had discarded CRS. The majority of the suspected cases were in the < 1-month age group (27.4%). Hearing loss was the most prevalent symptom in both the pre and post-rubella vaccination campaign (RVC) introduction periods campaign among groups. A patient with suspected CRS clinical signs.

Keywords: Congenital rubella syndrome; Infectious disease; Rubella vaccination campaign; Surveillance.